Proposed Rule suggests Significant Change to Accreditation Process

Published in Government Relations on July 10, 2025

The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications.

Do Accrediting Organizations Have The Bandwidth? 

Under the new proposal, Accrediting Organizations (AOs) will be tasked with tripling their reaccreditation workload. This poses a serious question: Do AOs have the infrastructure, staffing, and systems in place to maintain the quality and rigor of their evaluations under this accelerated schedule? 

Traditionally, reaccreditation every three years has allowed AOs sufficient time to conduct thorough assessments and offer meaningful feedback to suppliers. Compressing this timeline could risk superficial evaluations, backlog issues, and increased pressure on both accrediting bodies and suppliers to meet compliance standards efficiently. 

Potential Impact on DME Suppliers

Currently, DME suppliers pay an annual fee plus survey fees for accreditation. With the proposed annual requirement, there are several questions as to how AOs will restructure their pricing model to accommodate more frequent surveys and potentially substantial increase in cost to suppliers. 

Final Thoughts 

As the proposed rule undergoes review, stakeholders — from suppliers to AOs — should be actively engaged in assessing the logistical and financial impacts. These decisions will affect not only business operations but also patient access and care quality. Transparency, preparedness, and collaborative planning are critical as this shift unfolds. 

Public Comment Period: Make Your Voice Heard  

It is critical for DME suppliers and stakeholders to participate in the public comment period to ensure that industry perspectives are reflected in the final policy.  

  1. Deadline for Comments: Comments must be received no later than 5 p.m. EDT on August 29.  
  2. Reference: Please include file code CMS-1828-P in your submission.  
  3. Note: CMS cannot accept comments via fax due to staffing and resource limitations.  

How to Submit Comments  

Go to the federal register proposed rule:   

Choose one of the following methods to submit your feedback:  

  1. Electronically: Submit comments at Regulations.gov. Follow the instructions under the “Submit a Comment” tab.   
  2. By mail: Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1828-P P.O. Box 8013 Baltimore, MD 21244-8013 (Ensure timely delivery before the deadline).  
  3. By express or overnight mail: Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1828-P Mail Stop C4-26-05 7500 Security Boulevard Baltimore, MD 21244-1850  

VGM Is With You Every Step Of The Way  

VGM has stood by the DMEPOS community through every round of competitive bidding—and this time is no different. We remain committed to supporting suppliers throughout this process and will continue to provide resources and guidance along the way.  

Stay tuned for more insights as the rulemaking process unfolds.  

From Our Experts

August Of Action: Your Chance To Connect With Congress thumbnail August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you. HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement. The Return of Competitive Bidding thumbnail The Return of Competitive Bidding The Centers for Medicare & Medicaid Services (CMS) appear to be laying the groundwork for another round of the Competitive Bidding Program (CBP). While full implementation will take a couple of years, an official announcement is expected this summer—potentially as early as July.